The introduction of lower-priced options and expanding insurance coverage arent always a win for patients
[16] [17] Semaglutide (as Wegovy) is further indicated as an adjunct to a reduced-calorie diet and increased physical activity for weight management, including weight loss and weight maintenance, in adults with obesity (initial BMI 30 kg/m 2 ) or who are overweight (initial BMI 27 kg/m 2 ) and have at least one weight-related comorbidity such as dysglycemia (prediabetes or type 2 diabetes), hypertension, dyslipidemia, or cardiovascular disease
The three main spots professionals use are: Upper arm (deltoid) The quick and easy go-to
Clin Exp Pharmacol Physiol 24:907915 Miners JO, Knights KM, Houston JB et al (2006) In vitro-in vivo correlation for drugs and other compounds eliminated by glucuronidation in humans: pitfalls and promises
Im +40 lbs down and counting
Understanding these variables helps contextualise any changes observed during treatment and prevents unnecessary anxiety